Skip to content

Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study

Implementing Collaborative Care to Alleviate Symptoms and Adjust to Heart Failure: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01581008
Acronym
CASA
Enrollment
31
Registered
2012-04-19
Start date
2011-10-31
Completion date
2012-12-31
Last updated
2018-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure (CHF)

Keywords

palliative care, heart failure, delivery of health care

Brief summary

The overall goal of this study is to evaluate the pilot implementation of two palliative care interventions in veterans with chronic heart failure at the Denver VA Medical Center. This is a study of behavioral and care strategy interventions and involves no investigational drugs or devices.

Detailed description

The investigators will examine the feasibility of two palliative care interventions designed to improve different facets of quality of life. Briefly, the two interventions are: 1. A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes 1. evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse; 2. a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and 3. brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider. 2. A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support. The specific aims of the study are to: 1. Examine intervention feasibility and determine preliminary estimates of intervention effect 1. Determine patient participation rates and cohort retention 2. Conduct a preliminary assessment of outcomes by measuring pre-post changes in quality of life, depressive symptoms, health status, life meaning, and spirituality. 2. Obtain qualitative feedback from study participants, the persons providing the intervention, and providers/leaders in primary care, mental health, palliative care, chaplaincy, and hospital operations.

Interventions

OTHERCollaborative Care to Alleviate Symptoms and Adjust to Illness

A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes (a) evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse; (b) a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and (c) brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider.

BEHAVIORALPsychospiritual

A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support.

Sponsors

University of Iowa
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* eligible veterans from the Denver VAMC will have a prior primary discharge diagnosis of heart failure in the last year, * be at least 18 years of age, able to read and understand English, * have consistent access to a telephone * at least one of the following: 1. Kansas City Cardiomyopathy Questionnaire (KCCQ) score less than or equal to 60; 2. a second hospitalization for with a primary discharge diagnosis of heart failure in the last year; 3. taking at least 80 mg oral furosemide (or equivalent) daily in a single or divided dose for at least 2 weeks; 4. BNP greater than or equal to 250 or NT-proBNP greater than or equal to 1000; or 5. estimated creatinine clearance 30-80 mL/min.

Exclusion criteria

* previous diagnosis of dementia; * active substance abuse, defined as an AUDIT-C score greater than 7, two positive responses on substance abuse screening questions, or medical records indicating active substance abuse or dependence; * comorbid metastatic cancer, given the focus on heart failure palliative care; * nursing home resident; and * diagnosis of bipolar disorder or schizophrenia.

Design outcomes

Primary

MeasureTime frameDescription
Cohort Retention3 monthsCohort retention will be determined by examining the proportion of patients who complete the final study visit (at 3-month follow-up) over the total number of patients enrolled in the study (including deceased and lost-to-follow-up). Our goal is an 80% retention rate for this pilot study.

Secondary

MeasureTime frameDescription
Was Depression Addressed?3 monthsThe Patient Health Questionnaire-9 (PHQ-9) rates nine DSM-IV criteria of depression on a 0 (not at all) to 3 (nearly every day) scale. Scale range is 0-27, with depression severity scored: 0-4 (none), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). The suicidal item is thoughts that you would be better off dead, or of hurting yourself in some way?
Participation Rates7 monthsThe investigators will use a CONSORT diagram to display participant flow, and determine how many of those who were approached enrolled in the trial.
Adherence to the Study Protocol (CASA Arm Only)3 monthsThe investigators will calculate percentage adherence to pre-specified tasks on the intervention protocol, such as: * how often is depression addressed with a treatment plan? * how often are care team recommendations placed as orders in the medical record? * how often are orders completed?

Countries

United States

Participant flow

Pre-assignment details

One participant was a screen failure, thus 30 patients completed baseline surveys and were randomized.

Participants by arm

ArmCount
CASA
A palliative symptom management and psychosocial care intervention named Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) that includes (a) evidence-based palliative symptom management of breathlessness, fatigue, and pain, provided by a nurse; (b) a 6-session structured psychosocial care protocol targeting depression and adjustment to illness, supplemented by informal (family) caregiver assessment and support, provided by a social worker or psychologist; and (c) brief weekly team meetings with the nurse, social worker/psychologist and a palliative care specialist, cardiologist, and primary care provider.
17
Psychospiritual
A psychospiritual intervention that is home-based, self-guided, and requires minimal resources. It will be delivered in written modular form via US Mail along with brief weekly telephone support.
13
Total30

Baseline characteristics

CharacteristicCASAPsychospiritualTotal
Age, Continuous63 years65 years63 years
Region of Enrollment
United States
17 participants13 participants30 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
17 Participants13 Participants30 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 170 / 13
serious
Total, serious adverse events
0 / 170 / 13

Outcome results

Primary

Cohort Retention

Cohort retention will be determined by examining the proportion of patients who complete the final study visit (at 3-month follow-up) over the total number of patients enrolled in the study (including deceased and lost-to-follow-up). Our goal is an 80% retention rate for this pilot study.

Time frame: 3 months

ArmMeasureValue (NUMBER)
CASACohort Retention16 participants
PsychospiritualCohort Retention7 participants
Secondary

Adherence to the Study Protocol (CASA Arm Only)

The investigators will calculate percentage adherence to pre-specified tasks on the intervention protocol, such as: * how often is depression addressed with a treatment plan? * how often are care team recommendations placed as orders in the medical record? * how often are orders completed?

Time frame: 3 months

Population: A variety of process information was analyzed. Please see Bekelman DB et al, Feasibility and acceptability of a collaborative care intervention to improve symptoms and quality of life in chronic heart failure: mixed methods pilot trial Journal of Palliative Medicine 2014, PMID 14329424 for details.

ArmMeasureValue (NUMBER)
CASAAdherence to the Study Protocol (CASA Arm Only)94 %in arm severe target symptoms addressed
Secondary

Participation Rates

The investigators will use a CONSORT diagram to display participant flow, and determine how many of those who were approached enrolled in the trial.

Time frame: 7 months

Population: The total population approached was 72 people. 31 consented to be randomized for a participate rate of 43%. Of these, one was a screen failure, and 17 and 13 were randomized to arm 1 and arm 2 respectively.

ArmMeasureValue (NUMBER)
CASAParticipation Rates17 participants
PsychospiritualParticipation Rates13 participants
Secondary

Was Depression Addressed?

The Patient Health Questionnaire-9 (PHQ-9) rates nine DSM-IV criteria of depression on a 0 (not at all) to 3 (nearly every day) scale. Scale range is 0-27, with depression severity scored: 0-4 (none), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). The suicidal item is thoughts that you would be better off dead, or of hurting yourself in some way?

Time frame: 3 months

Population: This analysis was only conducted in CASA participants

ArmMeasureGroupValue (NUMBER)
CASAWas Depression Addressed?Baseline PHQ9 suicidal item >=12 participants
CASAWas Depression Addressed?Baseline PHQ9 score >=104 participants
CASAWas Depression Addressed?PHQ9 score >=10 addressed w/ treatment plan4 participants
CASAWas Depression Addressed?PHQ9 suicidal item >=1 addressed w/ treatment plan2 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026